J

Jinling Pharmaceutical Co Ltd
SZSE:000919

Watchlist Manager
Jinling Pharmaceutical Co Ltd
SZSE:000919
Watchlist
Price: 7.65 CNY -1.92% Market Closed
Market Cap: ¥4.8B

Wall Street
Price Targets

Price Targets Summary
Jinling Pharmaceutical Co Ltd

There are no price targets for Jinling Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Jinling Pharmaceutical Co Ltd Competitors:
Price Targets
THRY
Thryv Holdings Inc
182% Upside

Revenue
Forecast

3% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
3% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 7 years is 1%.

Operating Income
Forecast

-14% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss
-14% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-29%
Average Miss

For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's operating income is -14%. The projected CAGR for the next 7 years is 30%.

Net Income
Forecast

-10% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-39%
Average Miss
-10% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-39%
Average Miss

For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's net income is -10%. The projected CAGR for the next 7 years is 27%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jinling Pharmaceutical Co Ltd's stock price target?
Not Available

Jinling Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Jinling Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 7 years is 1%.

What is Jinling Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
30%

For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's operating income is -14%. The projected CAGR for the next 7 years is 30%.

What is Jinling Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
27%

For the last 13 years the compound annual growth rate for Jinling Pharmaceutical Co Ltd's net income is -10%. The projected CAGR for the next 7 years is 27%.

Back to Top